Skip to main content
. 2023 Jul 7;21:100724. doi: 10.1016/j.mtbio.2023.100724

Table 2.

A summary of the ECM used on tumor chips.

Category Gel condition Concentration range Advantages Disadvantages References
Rat tail collagen type I At a neutral pH 1.3–10.0 (mg/mL) Similar to the ECM of tumors, biodegradability, containing cell adhesive domains, commercially available Derived from animals, weak stability, monocomponent [55,[149], [150], [151], [152], [153], [154], [155]]
Matrigel Above room temperature 2.5%–10% (v/v) A variety of protein components, biodegradability, commercially available Derived from animals, undefined compositions, poor mechanical properties [[156], [157], [158], [159], [160], [161]]
Bovine fibrinogen Mixed with bovine thrombin 2.5–10.0 (mg/mL) Promoting the self-assembly of HUVECs, enzymatical degradability, occurring RGD adhesion domains, commercially available Risks of immunogen and pathogen, monocomponent [56,140,[162], [163], [164], [165]]
GelMA Exposure to light with the assistance of a photoinitiator 3%–10% (v/v) Customized components, easy to pattern, rapid prototyping, good biocompatibility and bioactivity, commercially available Risk of cell death induced by photoinitiators, lack of microscale pores to accommodate tumor cell migration, difficult to degrade [133,156,166,167]
Cultrex BME Above room temperature 2.5%–10% (v/v) Similar to an early developmental basement membrane, commercially available Risks of immunogen and pathogen, undefined compositions, poor mechanical properties [[168], [169], [170]]
dECM Chemical, biological and physical methods Reconstituted native ECM, customized components Expensive cost, risk of cytotoxicity, require a different protocol to ensure efficient decellularization [145,155]